Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

11/11/2022 06:30

Nov 11 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.90                1.62             2.61     
                   (+17.3 pct)        (+183.0 pct)      (-6.2 pct)  
  Operating          501 mln             107 mln          420 mln   
                  (+367.6 pct)                          (-40.6 pct) 
  Recurring          676 mln             238 mln          420 mln   
                  (+183.8 pct)                          (-51.3 pct) 
  Net                467 mln             169 mln          342 mln   
                  (+175.9 pct)                          (-54.7 pct) 
  EPS               22.28 yen           8.08 yen         16.34 yen  
  EPS Diluted       22.27 yen           8.08 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T